{"title":"泰国系统性红斑狼疮儿童的低骨密度:患病率和危险因素。","authors":"Ankanee Chanakul, Suriyaphon Khunrattanaphon, Tawatchai Deekajorndech","doi":"10.2478/abm-2021-0030","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Improvement of disease recognition and management has increased the survival of children with systemic lupus erythematosus (SLE), but has shifted the morbidity focus toward long-term complications, such as low bone mass and osteoporosis. Studies in adults with SLE show older age, chronic inflammation, and corticosteroid therapy are risk factors for low bone mineral density (BMD) and osteoporosis.</p><p><strong>Objectives: </strong>To determine the prevalence of and identify risk factors associated with low BMD in Thai children with SLE.</p><p><strong>Methods: </strong>We conducted a retrospective review of demographic data and clinical variables for a cohort of 60 Thai children with SLE who underwent 2 dual-energy X-ray absorptiometry (DXA) at their initial examination and later follow-up. We considered a BMD <i>z</i> score ≤ -2.0 to indicate low BMD. Binary logistic regression was used to assess risk factors potentially associated with low BMD.</p><p><strong>Results: </strong>The prevalence of low BMD at the first visit was 40% and increased to 55% over follow-up. We found a significantly decreased hip BMD <i>z</i> score (median difference -0.25, 95% confidence interval [CI] -0.40 to -0.05; <i>P</i> = 0.016) and lumbar BMD <i>z</i> score (median difference -0.49, 95% CI -0.69 to -0.28; <i>P</i> < 0.001) over time. The cumulative steroid dose tended to be higher for patients with low BMD (adjusted odds ratio [OR] = 1.08, 95% CI 1.00 to 1.17; <i>P</i> = 0.050).</p><p><strong>Conclusion: </strong>Low BMD has a 40% prevalence in Thai children newly diagnosed with SLE and progresses significantly over time. Higher cumulative corticosteroid dose tended to be associated with a low BMD, but we did not find a significant risk in this small sample.</p>","PeriodicalId":8501,"journal":{"name":"Asian Biomedicine","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388791/pdf/","citationCount":"0","resultStr":"{\"title\":\"Low bone mineral density in Thai children with systemic lupus erythematosus: prevalence and risk factors.\",\"authors\":\"Ankanee Chanakul, Suriyaphon Khunrattanaphon, Tawatchai Deekajorndech\",\"doi\":\"10.2478/abm-2021-0030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Improvement of disease recognition and management has increased the survival of children with systemic lupus erythematosus (SLE), but has shifted the morbidity focus toward long-term complications, such as low bone mass and osteoporosis. Studies in adults with SLE show older age, chronic inflammation, and corticosteroid therapy are risk factors for low bone mineral density (BMD) and osteoporosis.</p><p><strong>Objectives: </strong>To determine the prevalence of and identify risk factors associated with low BMD in Thai children with SLE.</p><p><strong>Methods: </strong>We conducted a retrospective review of demographic data and clinical variables for a cohort of 60 Thai children with SLE who underwent 2 dual-energy X-ray absorptiometry (DXA) at their initial examination and later follow-up. We considered a BMD <i>z</i> score ≤ -2.0 to indicate low BMD. Binary logistic regression was used to assess risk factors potentially associated with low BMD.</p><p><strong>Results: </strong>The prevalence of low BMD at the first visit was 40% and increased to 55% over follow-up. We found a significantly decreased hip BMD <i>z</i> score (median difference -0.25, 95% confidence interval [CI] -0.40 to -0.05; <i>P</i> = 0.016) and lumbar BMD <i>z</i> score (median difference -0.49, 95% CI -0.69 to -0.28; <i>P</i> < 0.001) over time. The cumulative steroid dose tended to be higher for patients with low BMD (adjusted odds ratio [OR] = 1.08, 95% CI 1.00 to 1.17; <i>P</i> = 0.050).</p><p><strong>Conclusion: </strong>Low BMD has a 40% prevalence in Thai children newly diagnosed with SLE and progresses significantly over time. Higher cumulative corticosteroid dose tended to be associated with a low BMD, but we did not find a significant risk in this small sample.</p>\",\"PeriodicalId\":8501,\"journal\":{\"name\":\"Asian Biomedicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2021-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388791/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Biomedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2478/abm-2021-0030\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Biomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2478/abm-2021-0030","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:疾病认知和管理的改善提高了系统性红斑狼疮(SLE)儿童的生存率,但已将发病重点转向长期并发症,如低骨量和骨质疏松症。对成人SLE患者的研究表明,年龄较大、慢性炎症和皮质类固醇治疗是低骨密度(BMD)和骨质疏松症的危险因素。目的:确定泰国SLE患儿低骨密度的患病率及相关危险因素。方法:我们对60名泰国SLE儿童进行了人口统计数据和临床变量的回顾性分析,这些儿童在初始检查和随后的随访中接受了2次双能x线吸收仪(DXA)。我们认为骨密度z评分≤-2.0表示骨密度低。采用二元逻辑回归评估与低骨密度相关的潜在危险因素。结果:首次就诊时骨密度低的患病率为40%,随访时上升至55%。我们发现髋部骨密度z评分显著降低(中位数差值-0.25,95%可信区间[CI] -0.40至-0.05;P = 0.016)和腰椎BMD z评分(中位差-0.49,95% CI -0.69 ~ -0.28;P < 0.001)。低骨密度患者的累积类固醇剂量倾向于更高(校正优势比[OR] = 1.08, 95% CI 1.00 ~ 1.17;P = 0.050)。结论:低骨密度在新诊断为SLE的泰国儿童中有40%的患病率,并且随着时间的推移进展显著。较高的皮质类固醇累积剂量往往与低骨密度相关,但我们在这个小样本中没有发现显著的风险。
Low bone mineral density in Thai children with systemic lupus erythematosus: prevalence and risk factors.
Background: Improvement of disease recognition and management has increased the survival of children with systemic lupus erythematosus (SLE), but has shifted the morbidity focus toward long-term complications, such as low bone mass and osteoporosis. Studies in adults with SLE show older age, chronic inflammation, and corticosteroid therapy are risk factors for low bone mineral density (BMD) and osteoporosis.
Objectives: To determine the prevalence of and identify risk factors associated with low BMD in Thai children with SLE.
Methods: We conducted a retrospective review of demographic data and clinical variables for a cohort of 60 Thai children with SLE who underwent 2 dual-energy X-ray absorptiometry (DXA) at their initial examination and later follow-up. We considered a BMD z score ≤ -2.0 to indicate low BMD. Binary logistic regression was used to assess risk factors potentially associated with low BMD.
Results: The prevalence of low BMD at the first visit was 40% and increased to 55% over follow-up. We found a significantly decreased hip BMD z score (median difference -0.25, 95% confidence interval [CI] -0.40 to -0.05; P = 0.016) and lumbar BMD z score (median difference -0.49, 95% CI -0.69 to -0.28; P < 0.001) over time. The cumulative steroid dose tended to be higher for patients with low BMD (adjusted odds ratio [OR] = 1.08, 95% CI 1.00 to 1.17; P = 0.050).
Conclusion: Low BMD has a 40% prevalence in Thai children newly diagnosed with SLE and progresses significantly over time. Higher cumulative corticosteroid dose tended to be associated with a low BMD, but we did not find a significant risk in this small sample.
期刊介绍:
Asian Biomedicine: Research, Reviews and News (ISSN 1905-7415 print; 1875-855X online) is published in one volume (of 6 bimonthly issues) a year since 2007. [...]Asian Biomedicine is an international, general medical and biomedical journal that aims to publish original peer-reviewed contributions dealing with various topics in the biomedical and health sciences from basic experimental to clinical aspects. The work and authorship must be strongly affiliated with a country in Asia, or with specific importance and relevance to the Asian region. The Journal will publish reviews, original experimental studies, observational studies, technical and clinical (case) reports, practice guidelines, historical perspectives of Asian biomedicine, clinicopathological conferences, and commentaries
Asian biomedicine is intended for a broad and international audience, primarily those in the health professions including researchers, physician practitioners, basic medical scientists, dentists, educators, administrators, those in the assistive professions, such as nurses, and the many types of allied health professionals in research and health care delivery systems including those in training.